Patent application number | Description | Published |
20110308981 | SEALED POUCHES FOR MEDICAL DEVICES HAVING TEXTURED OPENING FLANGES AND METHODS THEREFOR - A sealed foil pouch has a textured opening flange and includes first and second foil sheets having opposing inner surfaces joined together by a seal for defining a sealed area of the pouch located inside the seal and an unsealed area of the pouch located outside the seal. The sealed pouch includes a textured opening flange located adjacent an edge of the pouch for peeling the first and second foil sheets away from one another for breaking the seal and opening the sealed pouch. The textured opening flange is located within the unsealed area of the pouch and includes at least one roughened surface formed on at least one of the first and second sheets. A leg of the seal passes through the textured opening flange. The roughened surface makes it easier to break the leg of the seal for pulling the sheets apart. | 12-22-2011 |
20110308983 | DISPENSING PACKAGES FOR MEDICAL DEVICES HAVING TWO COMPONENTS THAT ARE MECHANICALLY INTERLOCKED AND METHODS THEREFOR - A package for a flat medical implant includes a flexible outer component, such as Tyvek®, including a first panel and a second panel foldable over said first panel for closing the package, and an inner component, such as paper, mechanically interlocked with the flexible outer component. A flat medical implant is held by the inner component. While the outer and inner components remains mechanically interconnected to one another, the upper ends of the first and second panels of the outer component are peelable away from one another for opening the package and accessing the flat medical implant at an upper end of the package. | 12-22-2011 |
20110309073 | OUTER BOXES FOR STORING AND DELIVERING MEDICAL DEVICES USED DURING SURGICAL PROCEDURES AND METHODS THEREFOR - A box for a medical device includes a first panel, a second panel hingedly connected with a lower edge of the first panel, a third panel hingedly connected with a lower edge of the second panel, a first side flap hingedly connected with a first side of the first panel, and a second side flap hingedly connected with a second side of the first panel. The third panel is folded over the second panel and the second panel is folded over the first panel for forming a first storage compartment and a separate second storage compartment. The first and second side flaps are folded over the second panel for closing the sides of the box. The box includes a cover foldable over and interlockable with the first side flap, the second panel, and the second side flap for holding the cover closed and closing the box. | 12-22-2011 |
20120217176 | DISPENSING PACKAGES FOR MEDICAL DEVICES HAVING TWO COMPONENTS THAT ARE MECHANICALLY INTERLOCKED AND METHODS THEREFOR - A package for a flat medical implant includes a flexible outer component, such as Tyvek®, including a first panel and a second panel foldable over said first panel for closing the package, and an inner component, such as paper, mechanically interlocked with the flexible outer component. A flat medical implant is held by the inner component. While the outer and inner components remains mechanically interconnected to one another, the upper ends of the first and second panels of the outer component are peelable away from one another for opening the package and accessing the flat medical implant at an upper end of the package. | 08-30-2012 |
20150122681 | MULTI-COMPONENT PACKAGES FOR MEDICAL DEVICES - A package for a medical device includes a tray having elements that receive a medical device. The tray has proximal retainer posts for limiting proximal movement of the medical device relative to the tray. The package includes a retainer lid secured to the tray for covering the top surface of the tray at the distal end of the tray, and a retainer sleeve that is wrapped around the top and bottom surfaces of the tray and secured to the tray by the retainer lid. The proximal end of the retainer sleeve includes a top panel that covers the top surface of the tray at the proximal end of the tray. The top panel of the retainer sleeve has a free edge that is adapted to flex away from the top surface of said tray so that the medical device can be grasped. | 05-07-2015 |
Patent application number | Description | Published |
20080201007 | Methods and systems for making a blood vessel sleeve - Methods, apparatuses, computer program products, devices and systems are described that include accepting one or more blood vessel sleeve dimensions based on blood vessel data from an individual; and making a rapid-prototyped blood vessel sleeve at least partly based on the one or more blood vessel sleeve dimensions. | 08-21-2008 |
20080262341 | Active blood vessel sleeve methods and systems - Methods, apparatuses, computer program products, devices and systems are described that include accepting one or more blood vessel sleeve dimensions based on blood vessel data from an individual; and making a rapid-prototyped blood vessel sleeve at least partly based on the one or more blood vessel sleeve dimensions. | 10-23-2008 |
20140377319 | ALTERING PROTEIN CONCENTRATIONS IN CEREBROSPINAL FLUID AND/OR BRAIN INTERSTITIAL FLUID - Devices and methods of altering protein concentrations in cerebrospinal fluid and/or brain interstitial fluid are disclosed. Devices include a support having at least one protease attached to the support. The device may further include a housing. Devices may be implantable for use in an in vivo active flow system or for use in an in vivo passive system. Devices may also be used in an ex vivo active flow system. Devices may also be used in a passive system to treat cerebrospinal fluid and/or brain interstitial fluid that is withdrawn, or in a passive system that is implanted surgically. Methods include contacting cerebrospinal fluid and/or brain interstitial fluid with a support including at least one protease attached to the support. Proteins contained in the cerebrospinal fluid and/or brain interstitial fluid are cleaved by the protease resulting in the reduction of protein in cerebrospinal fluid and/or brain interstitial fluid. Additionally, methods are disclosed for treating neurodegenerative diseases and neurological disorders. | 12-25-2014 |